Health Catalyst, Inc. Stock

Equities

HCAT

US42225T1079

Software

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
6.03 USD +7.68% Intraday chart for Health Catalyst, Inc. +8.06% -34.88%
Sales 2024 * 309M Sales 2025 * 345M Capitalization 353M
Net income 2024 * -62M Net income 2025 * -54M EV / Sales 2024 * 2.21 x
Net Debt 2024 * 330M Net Debt 2025 * 311M EV / Sales 2025 * 1.93 x
P/E ratio 2024 *
-6.08 x
P/E ratio 2025 *
-7.34 x
Employees 1,300
Yield 2024 *
-
Yield 2025 *
-
Free-Float 96.49%
More Fundamentals * Assessed data
Dynamic Chart
1 day+7.68%
1 week+8.06%
Current month-19.92%
1 month-19.49%
3 months-41.46%
6 months-11.06%
Current year-34.88%
More quotes
1 week
5.45
Extreme 5.445
6.07
1 month
5.45
Extreme 5.445
7.74
Current year
5.45
Extreme 5.445
11.41
1 year
5.45
Extreme 5.445
14.37
3 years
5.45
Extreme 5.445
59.50
5 years
5.45
Extreme 5.445
59.50
10 years
5.45
Extreme 5.445
59.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 11-08-31
Director of Finance/CFO 40 13-03-31
Chief Operating Officer 61 12-11-30
Members of the board TitleAgeSince
Chairman 71 15-11-14
Director/Board Member 64 17-05-11
Director/Board Member 49 16-04-27
More insiders
Date Price Change Volume
24-04-26 6.03 +7.68% 692,177
24-04-25 5.6 -7.13% 699,349
24-04-24 6.03 +7.68% 781,634
24-04-23 5.6 +0.72% 493,212
24-04-22 5.56 -0.36% 601,349

Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT

More quotes
Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The Company’s solution comprises its cloud-based data and analytics platform, software applications, and professional services expertise. The Company operates through two segments: Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and is focused primarily on contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its customers to fully configure and utilize the benefits of its technology offerings. Its clients include academic medical centers, integrated delivery networks, community hospitals, physician practices, health insurers, and others.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
6.03 USD
Average target price
12 USD
Spread / Average Target
+99.00%
Consensus